Browsing Tag
BP1003
1 post
Bio-Path Holdings unveils preclinical success for BP1001-A in treating obesity and Type 2 diabetes
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology innovator known for leveraging its DNAbilize liposomal delivery platform, has announced…